baber/WOPTO huggingface dataset:
Patent JP-2000514825-A (JP)
IPC: A61K31/5395
Filed: 1997-12-04
Abstract: PCT No. PCT/EP97/06781 Sec. 371 Date Jun. 14, 1999 Sec. 102(e) Date Jun. 14, 1999 PCT Filed Dec. 4, 1997 PCT Pub. No. WO98/26779 PCT Pub. Date Jun. 25, 1998The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in the 7-position by a 2-oxa-5,8-diazabicyclo[4.3.0]-non-8-yl) radical, and their pharmaceutically utilizable hydrates and/or salts for the therapy of Helicobacter pylori infections and the gastroduodenal disorders associated therewith.
Patent JP-2001506997-A (JP)
Title: ホスホチロシン認識ユニットを有する蛋白質の修飾物質
IPC: A61P43/00
Filed: 1996-12-16
Abstract: (57)【要約】
本発明は式（Ａ１）Ｙ−Ｘ−Ｃ（Ｒ’）＝Ｃ（Ｒ”）ＣＯＯＲ'''で示される一般的構造を有する新規蛋白質チロシンホスファターゼ変調化合物、その調製方法、該化合物を含む組成物、ヒトおよび動物の障害の治療のためのその使用、および蛋白質または糖蛋白質の精製のためのその使用、診断におけるその使用に関する。本発明は、イン・ビトロ系、微生物、真核生物細胞、全動物およびヒトにおいて、蛋白質チロシンホスファターゼ（ＰＴＰａｓｅ）およびＳｒｃ−相同性−２ドメインを持つ蛋白質を含めた、ホスホチロシン認識ユニットを持つ分子の活性の変調に関する。Ｒ’およびＲ”は、独立して、水素、ハロ、シアノ、ニトロ、トリハロメチル、アルキル、アリールアルキルよりなる群から選択される。Ｒ'''は水素、アルキル、置換アルキル、アリール、アリールアルキルよりなる群から選択される。Ｘはアリールである。Ｙは水素またはαから選択され、ここに（ * ）はＸに対する結合の可能な点を示す。
Patent JP-2000508439-A (JP)
Title: 光学素子、前記光学素子を備えたディスプレイ装置及び該光学素子の製造方法
IPC: G02F1/1335
Filed: 1998-01-07
Abstract: (57)【要約】
フォトクロミック材料を含有する透明コーティング（９）を備えた基体を含む光学素子であって、前記光学素子の透過率は、可視領域において、光の変化に応じて変化する。この光学素子は、コーティング（９）が、酸化ケイ素の無機網状構造と、Ｓｉ−Ｃ結合を介して無機網状構造に化学的に結合する有機ポリマーを含有することを特徴とする。好ましくは、金属酸化物の巨視的粒子がこの網状構造に組込まれ、金属はＡｌ，Ｓｉ，Ｔｉ，Ｚｒ，Ｉｎ及びＳｎから成る群より選ばれるのが好ましい。好ましくは、金属酸化物は、その寸法が５ｎｍ以上のものを使用する。かかるフォトクロミックコーティング（９）は耐スクラッチ性を有し、良好なスイッチング挙動を示す。このコーティングは、例えばディスプレイ装置（１）のディスプレイウィンドウに、そしてサングラスに用いることができる。上記層の製造方法も開示する。
Patent JP-H11504051-A (JP)
Title: オキサ―及びチア―ジアゾールムスカリン受容体アンタゴニスト
IPC: A61P25/28
Filed: 1997-02-04
Abstract: (57)【要約】
式：
 [式中、Ｒ 1 はＣ 1 −Ｃ 6 アルキル、ハロ−(Ｃ 1 −Ｃ 6 アルキル)、Ｃ 3 −Ｃ 7 シクロアルキル、Ｃ 2 −Ｃ 6 アルキニル、ヒドロキシ−(Ｃ 2 −Ｃ 6 アルキニル)、（Ｃ 1 −Ｃ 4 アルコキシ）−(Ｃ 2 −Ｃ 6 アルキニル)、アリール、アリール−(Ｃ 1 −Ｃ 4 アルキル)、ヘテロアリールまたはヘテロアリール−（Ｃ 1 −Ｃ 4 アルキル）であり；Ｒ 2 はＨまたはＣ 1 −Ｃ 4 アルキルであり；Ｒ 3 はアリール、ヘテロアリール、2,3-ジヒドロベンゾフラニルまたはＣ 4 −Ｃ 7 シクロアルキルであり；ＸはＯまたはＳであり；及びＹは直接結合、−ＣＨ 2 −、−（ＣＨ 2 ） 2 −または−ＣＨ 2 Ｏ−である]の化合物または医薬的に許容可能なその塩。本化合物は、過敏性腸症候群及び尿失禁などの治療に有用なムスカリン受容体アンタゴニストである。本化合物は、認識エンハンサーとしても有用である。
Patent JP-2000505579-A (JP)
Title: 導電性ポリマーから形成される導体トラックを含む集積回路カード
IPC: H05K1/11
Filed: 1997-02-21
Abstract: (57)【要約】
導電性ポリマーから形成される所定パターンの湾曲導体を介してコンタクト領域（５）に接続されるピン（６）を具えた集積回路（７）を含むカードが開示される。
Patent JP-2000507327-A (JP)
Title: 内燃機関のための燃料噴射装置
IPC: F02M61/10
Filed: 1997-09-13
Abstract: (57)【要約】
内燃機関のための燃料噴射装置であって、高圧ポンプ１によって燃料を充填可能な共通の高圧集合室７（コモンレール）が設けられており、この高圧集合室が、噴射管路９を介して、燃料供給しようとする内燃機関の燃焼室内に突入する噴射弁１１に接続されており、これらの噴射弁の開閉動作がその都度、電気的に制御された制御弁１３によって制御されるようになっており、制御弁が３ポート２位置方向切換弁として形成されており、この制御弁が、噴射弁１１の噴射開口に開口する高圧通路２９を、噴射管路９または放圧管路３３に接続する。この場合、制御弁１３の制御弁部材２５に、燃料高圧を充填可能なハイドロリック的な作業室５１が設けられており、この作業室が、制御弁１３の制御弁部材２５の調節位置を調節するために、開制御されて放圧通路５７に連通可能である。
Patent JP-2000506927-A (JP)
IPC: C08F110/00
Filed: 1997-03-19
Abstract: A composition including polyalphaolefins that function as drag reducing agents and a process for the preparation of polyalphaolefins that function as drag reducing agents are disclosed. The process includes contacting alphaolefin monomers with catalyst particles in a polymerization mixture that includes a hydrocarbon solvent. The polymerization of the alphaolefin monomers produces polyalphaolefin drag reducing agents having an inherent viscosity of at least 10 dL/g. During polymerization of the polyalphaolcfin monomers, localized micelles compromising high molecular weight polyalphaolefin polymer are formed in micellar zones around the catalyst particles. The polymerization is conducted in the presence of a viscosity reducing agent that includes a substantially hydrophobic dispersant. The viscosity reducing agent is present in an amount sufficient to reduce the viscosity of the reaction mixture and disperse the localized micelles. The addition of the dispersant during the polymerization process provides for high molecular weight polyalphaolefin and a more uniform molecular weight distribution of the resulting polyalphaolefin. A process of forming a polyalphaolefin drag reducing agent in one or more polymerization reactors and a process for reducing drag in a conduit are also disclosed.
Patent JP-H11504967-A (JP)
Title: ハイド、スキン、革及び毛皮を界面活性剤により処理し、撥水効果を改善し、種々の湿潤青皮の品質に適合させる方法
IPC: C09K23/22
Filed: 1996-05-03
Abstract: (57)【要約】
ここでは、スキン、フェル(fell)、革及びペルトならびにその他の繊維材料を、湿式仕上げ作業場において、及び／又は防水処理前に湿潤青皮革を処理する際に特別な界面活性剤で処理することにより、これらの材料の防水処理を改善する方法を開示する。Ｎ−アシル−アミノ酸の塩をベースとする陰イオン系界面活性剤及びアルキルポリグリコシド又はポリエチレングリコールカルボキシアルキルエーテルのような非イオン系界面活性剤が特に適する。界面活性剤の使用量は、なめらかにしたスキンないしは裏削りした後のスキンの重量に対して０．５〜５重量％の範囲である。
Patent JP-2000508636-A (JP)
Title: 置換されたピリジン／ピリミジン、その製法および殺虫剤としてのその使用
IPC: A01N43/54
Filed: 1997-03-24
Abstract: (57)【要約】
本発明は、式Ｉ
 （式中、ＡはCHまたはＮであり；ＸはNH、酸素またはS(O) q （式中、ｑは０、１または２である）であり；Ｙは直接の結合またはCH 2 であり；Ｚは酸素、NR 7 またはS(O) m （式中、ｍは０、１または２である）であり、そして基R 1 、R 2 、R 3 、R 4 、R 5 、R 6 およびR 7 は明細書において定義した通りである）の新規な置換されたピリジン／ピリミジン、これらの化合物の製法および殺虫剤、殺菌剤、殺卵剤としてのまたは家畜医薬としてのこれらの化合物の使用に関するものである。
Patent JP-2000512337-A (JP)
Title: ポリマー組成物、その製造、容器、特に貯蔵又は輸送容器及び廃棄物容器へのその更なる加工、並びに容器内容物を保護するためのプラスチック含有材料におけるフェノール類の使用、特にそれらから製造される廃棄物容器におけるフェノール類の使用
IPC: B29C48/16
Filed: 1999-01-08
Abstract: (57)【要約】
本発明は、全組成に対して０．０１重量％〜１０重量％、好ましくは０．０５重量％〜２重量％の少なくとも１種のフェノールを含むことを特徴とするポリマー組成物に関し、対応するポリマーマスターバッチ並びにその製造及び使用にも関する。
Patent JP-2001513682-A (JP)
IPC: A61J1/20
Filed: 1998-02-26
Abstract: A penetrator for penetrating a stopper sealing an opening in a container. The penetrator includes a stamped piece of sheet material formed to define a shank having a length. A groove extends along the length of the shank. The shank has a pointed distal. The stamped piece of sheet material further includes a bearing plate extending from the shank at a proximal end opposite the distal end of the shank.
Patent JP-2001519840-A (JP)
Title: 冷却潤滑剤のための殺菌・殺かび性ベンゾチオフェン−２−カルボキサミド−ｓ，ｓ−ジオキシド類
IPC: C10N40/22
Filed: 1998-02-26
Abstract: (57)【要約】
本発明は、微生物活性から冷却潤滑剤を保護するためのＮ−アルキル−ベンゾチオフェン−２−カルボキサミドＳ，Ｓ−ジオキシド類の使用に関する。
Patent JP-2000509601-A (JP)
Title: 家畜用敷材
IPC: A47C27/08
Filed: 1997-04-22
Abstract: (57)【要約】
家畜用敷材は、流体の内圧によって膨張可能であって、支持領域を規定する少なくとも一枚の可撓性支持シートに作用する袋を備え、袋が膨張すると、支持シートが支持領域において略凸状形状をとる。袋は、少なくとも一方が支持シートである、上下に積層された第一可撓性シートと第二可撓性シートとの間に配置することができる。この敷材を使用する好ましい方法は、動物が立っている場合に、足による点荷重によって押された支持シートが、安定した基部に摩擦係合し、且つ動物が横になった場合には、動物の体の実質的に全体が袋内の流体によって基部から離隔されるように、袋内の流体圧又は流体量を特定の動物に合わせて選択する工程を含む。このような敷材の一体的な集合体が、好ましくは細長い帯状体の形態で開示される。この帯状体は、巻き上げた状態で提供することができ、設置時には簡単に広げて小割板で固定することができる。
Patent JP-2001515494-A (JP)
Title: 診断及び治療のための放射能標識したソマトスタチン受容体リガンド
IPC: A61K51/08
Filed: 1998-03-12
Abstract: (57)【要約】
本発明は、ソマトスタチン受容体陽性の腫瘍又は標的細胞の診断及び／又は放射能治療において使用される放射性核種のための担体物質に関する。ソマトスタチン−１４アゴニストと、ランレオチドと、及び金属放射性核種と種々の生理学的条件のもとで安定なキレートを形成する巨大環キレート化剤とからなる抱合体を対象とする。
Patent JP-2000510990-A (JP)
Title: 集積回路メモリ
IPC: G11C16/02
Filed: 1996-05-22
Abstract: (57)【要約】
フラッシュメモリデバイス（１０）は、多重チェックポイント消去中断アルゴリズムを含む。ユーザは、消去プロセス中の何時でも消去中断命令を発行することができる。消去論理回路（１２）に結合されている消去中断論理回路（１５）は、ブロック消去手順中、消去中断命令を受信した後のチェックポイントのセットの中で最初に出現するチェックポイント中にブロック消去手順に割り込む消去中断手順を実行する。ブロック消去手順に割り込んだ後に、消去中断手順は、ブロック消去を完了させるためにブロック消去手順への復帰を含む。
Patent JP-2001527657-A (JP)
IPC: G03G9/08
Filed: 1998-04-01
Abstract: There is described a process for producing a particulate composition comprising the steps of:(a) forming a first dispersion comprising first particles stabilised in a first fluid by a first species in an initial state, the first species changeable between the initial state and a further state, where the initial state provides (directly or indirectly) more stability to the particles within the dispersion than the further state;(b) optionally the step of forming a second dispersion comprising second particles stabilised in a second fluid, miscible with the first fluid, by a second species in the, or another, initial state, the second species also changeable between the, or another ,initial state and the, or another, further state, where said initial state provides (directly or indirectly) more stability to the particles within the dispersion than said further state;(c) after the optional step of mixing the first and second dispersions together if the second dispersion was formed in step b), changing the state(s) of the first and/or optionally second species from the initial state(s) to the further state(s) substantially to induce association between the dispersed particles to form clusters; and(d) binding together the particles within the clusters.A preferred embodiment of the process comprises mixing together two aqueous dispersions of particles (e.g. pigment particles with particles of latex polymer formed by emulsion polymerisation). The dispersions are stabilised by ionic surfactants of same sign charge. Association of the particles into clusters is induced by adjusting pH to selectively protonate or deprotonate the surfactants. The clusters are grown by aggregation into loose matrices which are fused together to form particles which can be used in electroreprographic toners.
Patent JP-2002501509-A (JP)
Title: Ｈｉｖの処置のための医薬の製造のためのｃｄ２６インヒビターの使用
IPC: A61K35/12
Filed: 1998-04-30
Abstract: (57)【要約】
HIVに感染したヒト患者の免疫応答を増大させるための医薬の調製のためのCD26を阻害する分子の使用であって、この免疫応答の増大は、インビトロまたはインビボで、Ｔ細胞増殖を引き起こすのに効果的な濃度ではあるが検出可能な細胞傷害性を引き起こす量未満のこの分子とＴ細胞とを接触させることによる。
Patent JP-2001524159-A (JP)
Title: 下降管によって生成物をろ過するスラリー炭化水素合成方法
IPC: C07C1/04
Filed: 1998-05-05
Abstract: (57)【要約】
炭化水素液体生成物は、スラリーに沈められたガス分離下降管を介してスラリーを反応装置の外側または内側のろ過域に循環させ、次いで反応装置のスラリー内に戻すことによって、炭化水素液体中に気泡と粒状触媒を含む３相炭化水素合成原料スラリーからろ過され、分離される。ガス分離はスラリーの密度を濃くし、高流動条件下にろ過面を通過させ、フィルター上のフィルターケーキとしての積層固形物を低下する。ろ過域を通過する循環は重力とスラリー密度の差による流体力学によって生じる。下降管はガスと固形物を減少する下降管であってもよい。
Patent NZ-201643-A (NZ)
Title: 1,5-diphenylpyrazolin-3-ones and pharmaceutical compositions
Inventor: HEINEMANN H
IPC: C07D231/22
Filed: 1982-08-19
Abstract: Intermediates of the isomeric formulae II or III    <IMAGE>  II <IMAGE> III  wherein R1 is a hydrogen or halogen atom, or a lower alkyl, lower alkoxy, hydroxyl, trifluoromethyl or lower alkanoyloxy group, R2 is a hydrogen or halogen atom, or a lower alkyl or lower alkoxy group, or R1 and R2 are bonded to adjacent carbon atoms and together denote a methylenedioxy or ethylenedioxy group, R3 is a hydrogen or halogen atom, or a lower alkyl, lower alkoxy, hydroxy, trifluoromethyl or lower alkanoyloxy group, R4 is a hydrogen or halogen atom, or a lower alkyl or lower alkoxy group, or R3 and R4 are bonded to adjacent carbon atoms and together denote a methylenedioxy or ethylenedioxy group, Z is an alkylene group with 2 to 6 carbon atoms, Z' is an alkylene group with 2 to 4 carbon atoms, Y is a halogen atom, and Y' is a halogen atom, and acid addition salts thereof, are useful to prepare antiallergic 2-piperazinoalkyl-1, 5-diphenylpyrazolin-3-ones.
Patent NZ-209052-A (NZ)
Title: Plastics container: inwardly folding hinged rim
Inventor: BOCK ERIK
IPC: B65D43/04
Filed: 1984-07-30
Abstract: A plastics container has a side wall (1 b) and a rim portion (2) moulded in one piece with the side wall. The rim portion (2) is joined to the side wall (1 b) by an integral hinge portion (3) on which it can be folded inwardly of the container. Thereby a container having an inwardly projecting rim or retaining tabs can be readily produced as a onepiece moulding. Preferably, the side wall (1 b) and rim portion (2) are inwardly concave, whereby the rim portion can be held in its inwards position by forces caused by folding.
Patent NZ-212614-A (NZ)
Title: Acetylenic phenoxypropanol derivatives and pharmaceutical compositions
Inventor: CARSON J R
IPC: A61K31/13
Filed: 1985-07-01
Abstract: Phenoxypropanol derivatives having a 2-acetylenic moiety on the phenyl group thereof of the following formula (I):   <IMAGE> (I)  and their use as anti-hypertensives, e.g. in man. Also part of the invention are pharmaceutical compositions and intermediates used in the synthesis.
Patent NZ-217629-A (NZ)
Title: Tear tab plastics lid closure
Inventor: PAVELY A P
IPC: B65D17/00
Filed: 1986-09-18
Abstract: A metal can end with a tear-open plastics closure in which the closure has a plug part (14) fitting into an aperture (11) in the can end, a rim (17) surrounding the plug part, an d a pull tab (15), wherein a groove (22) extends across the plug part (14) and aligned grooves (24,25) or interruptions extend across the rim (17) to provide a hinge line allowing the tab (15) and the adjacent portion (23) of the plug part to pivot upwardly to provide venting of the can in a first stage of opening before full opening of the closure in a second stage. The closure (12) is of the kind which is moulded on to the can end (10) so as to totally enclose a downturned flange (16) around the periphery of the aperture (11), and to be capable of being sheared against the flange on opening, and the residual thickness of the plastics material below the flange (16) is greater in the main portion than in the vent portion (23) of the closure to provide a temporary arrest after venting. The plug part (14) is stiffer than the metal of the can end so that doming of the can end under internal pressure is concentrated in the metal and the pull tab (15) extends at an angle to the can end surface, rendering it easier to grasp for opening the aperture. A second hinge line may be provided at the far end of the closure, with a further increase in residual thickness, so that the closure can be retained on the can end while being hinged out of the way for pouring.
Patent NZ-233474-A (NZ)
Title: Benzothiazolinone derivatives, preparation and pharmaceutical compositions thereof
Inventor: LESIEUR DANIEL
IPC: A61P25/04
Filed: 1990-04-27
Abstract: Compounds of general formula (I):   <IMAGE> (I)  in which: R1 represents a hydrogen atom or a lower alkyl group, R2 represents a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted thienyl, furyl, pyrrolyl or pyridinyl group, X represents a hydrogen atom, Y represents a hydroxyl group, or else X and Y together represent an oxygen atom, their enantiomers, diastereoisomers and epimers. Medicaments.
Patent NZ-240944-A (NZ)
Title: Multi-phasic contraception kit comprising 3 phases of increasing concentrations of progestogen; preparation thereof
Inventor: BERGINK ENGELBERT WILLEM
IPC: C07J1/00
Filed: 1991-12-11
Abstract: Disclosed is a contraceptive regimen, and method of using the regimen, comprising 24 daily sequential dosage units of: a first phase comprising about 7 to 9 separate first dosage units containing a progestogen at a daily dosage equivalent in progestogenic activity to 100  mu g desogestrel and an estrogen at a daily dosage equivalent in estrogenic activity to 25  mu g ethinyl estradiol ("EE"). A second phase of 7 to 9 second dosage units, each of the second dosage units containing a progestogen equivalent to 125  mu g desogestrel and an estrogen equivalent to 20  mu g EE. A third phase of 7 to 9 third dosage units, each unit containing a progestogen equivalent to 150 mu g desogestrel and an estrogen equivalent to 20  mu g EE. The kit generally has 28 daily dosage units wherein four of the daily dosage units contain no contraceptive steroid, or, alternatively, have only 24 dosage units with a four day "pill-free" period. The fourth phase may also be four dosage units containing a progestogen equivalent to 25 - 35  mu g desogestrel.
Patent NZ-243927-A (NZ)
Title: Parallel computer-printer interface with bidirectional communication
Inventor: PIPKINS JEFF D
IPC: G06F13/42
Filed: 1992-08-12
Abstract: A protocol provides bidirectional communication capability between a host computer and a printer over a parallel interface, the host computer and the printer having a forward channel therebetween for the transfer of signals from the host computer to the printer. The protocol includes conventions for turning the forward channel around so as to establish a reverse channel to allow transfer of data from the printer to the host computer, conventions for controlling the transfer of data from the printer to the host computer over the reverse channel, and conventions for turning the reverse channel back around so as to re-establish the forward channel. <IMAGE>
Patent NZ-248192-A (NZ)
Title: Polyvinylamine derivatives, preparation and use as microcapsules, medicament and foodstuff auxiliary
Inventor: AHLERS MICHAEL
IPC: A23L33/00
Filed: 1993-07-20
Abstract: The invention relates to polyvinylamine derivatives containing hydrophilic centres, of the formula I <IMAGE> in which R<1>, R<2>, R<3>, X, w, x, y and z are as defined, and to a process for their preparation, and to the use of these compounds as medicaments (drugs, pharmaceuticals), active compound (active ingredient) carriers and as foodstuff auxiliaries. The preparation starts, in particular, from highly pure polyvinylamines containing the recurring unit of the formula Ia <IMAGE> whose preparation is likewise described.a
Patent NZ-252850-A (NZ)
Title: Preparation of (s)-amino-1-substituted pyrrolidines from l-aspartic acid; aziridine intermediates
Inventor: VAN LE TUNG
IPC: C07D/
Filed: 1993-04-16
Abstract: 1-Benzyl-3(S)-Ä2-(S)-(tert.-butoxy-carbonylamino) propionylaminoÜ-pyrrolidine and its use as an intermediate.
Patent NZ-267423-A (NZ)
Title: (hetero)arylidene oxindoles and pharmaceutical compositions
Inventor: MARIANI MARIANGELA
IPC: C07C327/44
Filed: 1994-05-26
Abstract: Oxindole, acrylamide, thioacrylamide and acrylonitrile compounds, and their pharmaceutically acceptable salts, which are useful as tyrosine kinase inhibitors.
Patent NZ-277507-A (NZ)
Title: Foaming composition containing a finely powdered active pharmaceutical, in particular, mesalazine (5-asa)
Inventor: STAMM ANDRE
IPC: A61K9/00
Filed: 1994-12-14
Abstract: A composition for a foam and a process for preparing it are provided, the composition including by weight (a) more than 25% of an active ingredient in powder form; (b) from 1 to 20% of a surfactant; the balance being composed of water, wherein the powder of the active ingredient has a particle size below 20  mu m. Foams, notably for rectal administration, containing this composition with a propellant gas are also provided.
Patent NZ-284451-A (NZ)
Title: Preparation and stabilisation of cell suspensions by treatment with heavy metals and paraformaldehyde
Inventor: GRANGER VIVIAN
IPC: G01N33/569
Filed: 1997-01-27
Abstract: PCT No. PCT/EP95/01259 Sec. 371 Date Jan. 27, 1997 Sec. 102(e) Date Jan. 27, 1997 PCT Filed Apr. 5, 1995 PCT Pub. No. WO95/27203 PCT Pub. Date Oct. 12, 1995A stabilized cell suspension is prepared by treating the cell suspension with a solution of a heavy metal compound, which has been aged at pH 6.5-7.5 prior to use to allow a precipitate to form, removing the precipitate from the heavy metal solution, mixing the aged heavy metal solution with the cell suspension to form a first mixture, and mixing the first mixture with a paraformaldehyde solution to form a stabilized cell suspension which is still capable of lysis.
Patent NZ-309286-A (NZ)
Title: Asymmetric data communications system
Inventor: ARIAS SALVADOR LUIS
IPC: H04H20/00
Filed: 1996-05-23
Abstract: The specification describes an asymmetrical data communications system (ADCS) for point-to-multipoint television programming including conventional television programming, near video-on-demand (NVoD) or video-on-demand (VoD), and the full variety of available programming, via a compressed, digitized UHF transmission. A program subsystem of the ADCS receives programming from content providers and processes the received signals for channel and VoD or NVoD service, then sends the aggregated signal to a transmission subsystem that modulates, channelizes, amplifies, filters and broadcasts the digital UHF signals over the air. Subscribing viewers are equipped with an intelligent control box (ICB) suitably configured to receive, demodulate, and decode the digital UHF broadcast and to transmit the resulting signal to one or more display or other terminal devices. The ICB further provides a matrix switch or gateway for receiving signals over any available transmission path. In addition to the ICBs of the subscribing viewers, a return path subsystem of the ADCS system includes a session control and administrative facility to which the ICBs are linked via the public switched telephone network or suitable wireless alternative so that transaction and viewing data can be received from the subscribing viewers. The return path subsystem, in turn, is linked to the program subsystem in order to route to that subsystem any information necessary or useful for providing programming.
Patent NZ-330764-A (NZ)
Title: Water jet propulsion system, with adjustable inlet duct and outlet nozzle
Inventor: JORDAN JEFF P
IPC: B63H11/08
Filed: 1996-12-20
Abstract: A water jet propulsion system for a jet boat includes an adjustable water inlet duct 17, a pump 40 and adjustable inlet nozzle 62.  The inlet duct 17 includes a hydraulically efficient inlet tunnel 18, with an adjustable inlet opening 19 which adjusts in size according to the velocity of the boat through the water.  Using the inlet tunnel 18 and adjustable grate structure 22, the total dynamic head of the incoming water may be recovered at the pump.  The pump is larger than the pumps usually used on jet propulsion systems so that a greater flow of water at low head pressure may be delivered to the adjustable discharge nozzle 62.  The adjustability of the discharge nozzle enables the flow through the system to be adjusted so that the hydraulic conditions on the pump 40 are maintained at all boat speeds and all shaft rpms.
Patent NZ-500246-A (NZ)
Title: One piece pinless hinge for doors
Inventor: SLATTERY PHILLIP
IPC: E05D1/02
Filed: 1999-10-11
Abstract: A hinge 1 of the type having a pair of flexible hinging straps 3 which cross each other along an axis of swinging is claimed.  Strap 3 is connected at each end with mounting block means 5 which permit fixing of hinge 1 to structural members which are to be relatively hinged.  A mounting block means 5 is at one end of hinge straps 3, to define a right hand side wing 7 of hinge 1.  Another mounting block means 5 is at the other end of hinge straps 3, defining a left hand side wing 9 of hinge 1.
Patent NZ-501825-A (NZ)
Title: A cabinet having grooved edges for joining element
Inventor: FRANK MANFRED JOHANNES
IPC: A47F3/00
Filed: 1998-08-12
Abstract: A demountable cabinet (10) comprising walls (11) joined edge to edge by joiner elements (12). At the apex (15) of each intersection of the walls (11) there is a retainer (14). The retainers (14) prevent the joiner elements (12) from being removed. A locking retainer (16) is the last to be installed when the cabinet (10) is assembled, is lockable. The locking retainer (16) needs to be unlocked and removed before any of the joiner elements (12) and retainer elements (14) can be removed to disassemble the cabinet.